Enzychem Lifesciences Corporation (KOSDAQ:183490)
South Korea
· Delayed Price · Currency is KRW 1,039.00
-63.00 (-5.72%)
Mar 9, 2026, 3:30 PM KST
Enzychem Lifesciences Revenue
Enzychem Lifesciences had revenue of 16.47B KRW in the quarter ending September 30, 2025, a decrease of -3.18%. This brings the company's revenue in the last twelve months to 72.17B, down -12.06% year-over-year. In the year 2024, Enzychem Lifesciences had annual revenue of 77.38B with 1.76% growth.
Revenue (ttm)
72.17B
Revenue Growth
-12.06%
P/S Ratio
1.12
Revenue / Employee
555.16M
Employees
130
Market Cap
80.66B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kukje Pharma | 173.80B |
| Yuyu Pharma | 139.51B |
| CKD Bio | 159.93B |
| Ildong Holdings | 620.44B |
| MYUNGMOON Pharm co.,Ltd | 193.64B |
| Aprogen Biologics | 74.91B |
| Kyongbo Pharmaceutical | 252.20B |
| Jeil Pharma Holdings | 707.15B |